Robert R. Edelman

Robert R. Edelman's AcademicInfluence.com Rankings

Robert R. Edelman

Philosophy

#8437

World Rank

#11821

Historical Rank

Logic

#5472

World Rank

#6877

Historical Rank

philosophy Degrees

Robert R. Edelman

Biology

#11420

World Rank

#14813

Historical Rank

Microbiology

#650

World Rank

#719

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Robert R. Edelman's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Robert R. Edelman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert R. Edelman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant (1995) (1286)
Trichomonas vaginalis Associated With Low Birth Weight and Preterm Delivery (1997) (825)
Spirochetes isolated from the blood of two patients with Lyme disease. (1983) (752)
Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. (1999) (686)
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. (1995) (485)
Summary of an international workshop on typhoid fever. (1986) (414)
Efficacy of an acellular pertussis vaccine among adolescents and adults. (2005) (393)
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria (2010) (310)
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. (2000) (307)
Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer (2005) (306)
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis. (1984) (302)
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. (1996) (291)
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans (1997) (256)
Clinical responses to undiluted and diluted smallpox vaccine. (2002) (249)
Vaccination in the elderly: an immunological perspective. (2009) (219)
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers (1992) (197)
Phase 1 safety and immune response studies of a DNA vaccine encoding hepatitis B surface antigen delivered by a gene delivery device. (1999) (193)
Phase 2 Clinical Trial of AttenuatedSalmonella enterica Serovar Typhi Oral Live Vector Vaccine CVD 908-htrA in U.S. Volunteers (2000) (188)
Immunogenicity of recombinant LT-B delivered orally to humans in transgenic corn. (2004) (185)
Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. (1993) (183)
Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine. (2003) (174)
Efficacy of bovine milk immunoglobulin concentrate in preventing illness after Shigella flexneri challenge. (1992) (170)
Safety and Immunogenicity of Increasing Doses of aClostridium difficile Toxoid Vaccine Administered to Healthy Adults (2001) (170)
Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes. (2000) (167)
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. (1994) (165)
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. (2007) (165)
Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination (1999) (164)
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. (2004) (162)
Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates. (2003) (147)
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. (1992) (145)
Single-nutrient effects on immunologic functions. Report of a workshop sponsored by the Department of Food and Nutrition and its nutrition advisory group of the American Medical Association. (1981) (143)
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. (1992) (139)
Localization of Renin in Juxtaglomerular Cells of Rabbit and Dog Through the Use of the Fluorescent‐Antibody Technique (1961) (135)
Characteristics of three vaginal flora patterns assessed by Gram stain among pregnant women (1992) (135)
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system (1997) (134)
Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. (1973) (131)
Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres. (1994) (124)
Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). (2006) (124)
A randomized placebo-controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery (1991) (123)
Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults (2009) (123)
Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. (1997) (122)
Mechanisms of defective delayed cutaneous hypersensitivity in children with protein-calorie malnutrition. (1973) (121)
Three double-blind, randomized trials evaluating the safety and tolerance of different formulations of the saponin adjuvant QS-21. (2001) (120)
Incidence and cumulative frequency of endemic Lyme disease in a community. (1984) (115)
High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: a pilot study. (1996) (114)
Survey of human-use adjuvants (2003) (107)
Hepatitis c and cirrhotic liver disease in the Nile delta of Egypt: a community-based study. (2001) (105)
Dissemination of antibiotic-resistant bacteria across geographic borders. (2001) (105)
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge. (1995) (99)
Secretory and serum IgA in children with protein-calorie malnutrition. (1975) (98)
Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt (2002) (97)
Dengue vaccines approach the finish line. (2007) (97)
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. (1992) (96)
Summary of a workshop on enteropathogenic Escherichia coli. (1983) (96)
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. (1994) (90)
Safety and Immunogenicity of Live Oral Cholera Vaccine Candidate CVD 110, a ΔctxA ctxAzot zotace Derivative of El Tor Ogawa Vibrio cholerae (1993) (90)
Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. (1991) (89)
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide). (1993) (88)
Dengue vaccines: recent developments, ongoing challenges and current candidates (2013) (87)
CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. (1993) (86)
Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. (2008) (85)
Plasma kallikrein activation and inhibition during typhoid fever. (1978) (85)
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults. (2002) (83)
Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. (1993) (81)
The active E rosette test: correlation with delayed cutaneous hypersensitivity. (1976) (81)
New evidence for an inflammatory component in diarrhea caused by selected new, live attenuated cholera vaccines and by El Tor and Q139 Vibrio cholerae (1996) (77)
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvant. (1994) (77)
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination (1993) (77)
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. (2000) (75)
Lyme disease ecology in Wisconsin: distribution and host preferences of Ixodes dammini, and prevalence of antibody to Borrelia burgdorferi in small mammals. (1987) (74)
Phase 1 Safety and Pharmacokinetic Study of Chimeric Murine-Human Monoclonal Antibody cαStx2 Administered Intravenously to Healthy Adult Volunteers (2005) (74)
Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. IV. Vector studies. (1974) (73)
The active E-rosette test: a sensitive in vitro correlate for human delayed-type hypersensitivity. (1977) (73)
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. (1977) (72)
Phenotypic and Genotypic Characterization of Nosocomial Staphylococcus aureus Isolates from Trauma Patients (1998) (71)
Safety and immunogenicity of recombinant Bacille Calmette-Guérin (rBCG) expressing Borrelia burgdorferi outer surface protein A (OspA) lipoprotein in adult volunteers: a candidate Lyme disease vaccine. (1999) (70)
Validation of a Volunteer Model of Cholera with Frozen Bacteria as the Challenge (1998) (70)
Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation (2003) (69)
"Guidelines for the clinical evaluation of dengue vaccines in endemic areas": summary of a World Health Organization Technical Consultation. (2008) (68)
Study of Japanese encephalitis virus in Chiangmai Valley, Thailand. 3. Human seroepidemiology and inapparent infections. (1973) (67)
The epidemiology of acquired immunodeficiency syndrome among heterosexuals. (1988) (66)
Study of Japanese encephalitis virus in Chiangmai valley, Thailand. II. Human clinical infections. (1973) (66)
Quantitative Plasmodium sporozoite neutralization assay (TSNA). (2004) (63)
Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. (2009) (63)
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine. (2011) (63)
Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia. (2005) (61)
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. (1992) (61)
The development and use of vaccine adjuvants (2002) (60)
Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines. (2003) (59)
Acute medical problems in the Himalayas outside the setting of altitude sickness. (2000) (59)
Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein (2008) (58)
Immunoglobulins and antibody response in children with protein-calorie malnutrition. (1976) (58)
Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. (1986) (54)
Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84). (1979) (53)
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111. (1997) (53)
Clinical sequelae after japanese encephalitis: a one year follow-up study in Thailand. (1974) (52)
Perspective on the development and deployment of rotavirus vaccines. (1987) (52)
The epidemiology of antibody to hepatitis C in Egypt. (1993) (52)
Influence of the degree of metabolic control on physical fitness in type I diabetic adolescents. (1986) (52)
Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients: a retrospective matched cohort comparison with non-carriers. (2016) (50)
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. (1974) (49)
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax. (1991) (48)
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru (1997) (48)
Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. (1999) (47)
Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. (1994) (47)
Plasmodium falciparum Malaria Challenge by the Bite of Aseptic Anopheles stephensi Mosquitoes: Results of a Randomized Infectivity Trial (2010) (47)
Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate. (2011) (46)
Long-term safety assessment of live attenuated tetravalent dengue vaccines: Deliberations from a WHO technical consultation (2013) (44)
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. (1995) (42)
Two sequential outbreaks of rotavirus gastroenteritis: evidence for symptomatic and asymptomatic reinfections. (1988) (42)
Progress and controversy surrounding vaccines against Lyme disease (2003) (41)
Evaluation of the plasma kinin system in dengue hemorrhagic fever. (1975) (40)
Study of Japanese encephalitis virus in Chiangmia Valley, Thailand. VI. Summary and conclusions. (1974) (40)
Chicken-induced anaphylactoid reaction and colitis. (1994) (39)
Persistence of virus-specific IgM and clinical recovery after Japanese encephalitis. (1976) (39)
Assessing the Potential of a Candidate Dengue Vaccine with Mathematical Modeling (2012) (39)
From the National Institute of Allergy and Infectious Diseases. Summary of the National Institutes of Health workshop on group B streptococcal infection. (1983) (39)
Classification of HTLV-III/LAV-related diseases. (1985) (38)
An update on vaccine adjuvants in clinical trial. (1992) (38)
Study of Japanese encephalitis virus in Chiangmia Valley, Thailand. V. Animal infections. (1974) (36)
Summary of the International Symposium and Workshop on infections due to verocytotoxin (Shiga-like toxin)-producing Escherichia coli) (1988) (36)
Complement activity in children with protein-calorie malnutrition. (1976) (35)
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells. (1992) (35)
Infections at high altitude. (2001) (35)
Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. (2012) (33)
Dengue and dengue vaccines. (2005) (32)
Human immunoglobulin M antibody in the sero-diagnosis of Japanese encephalitis virus infections. (1973) (31)
Summary of a Workshop on Maternal Genitourinary Infections and the Outcome of Pregnancy (1983) (31)
Secretory and serum IgA in children with protein-calorie malnutrition. (1975) (31)
Interaction of alphaviruses with human peripheral leukocytes: in vitro replication of Venezuelan equine encephalomyelitis virus in monocyte cultures (1979) (31)
Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. (2002) (30)
An Overview of Adjuvant Use (2000) (30)
A randomized placebo‐controlled trial of erythromycin for the treatment of Ureaplasma urealyticum to prevent premature delivery (1992) (29)
Teachers in the Movies. (1983) (29)
Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal. (1999) (28)
Successful Human Infection with P. falciparum Using Three Aseptic Anopheles stephensi Mosquitoes: A New Model for Controlled Human Malaria Infection (2013) (28)
Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults. (2004) (27)
The effect of dengue virus infection on the clinical sequelae of Japanese encephalitis: a one year follow-up study in Thailand. (1975) (26)
Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection (2015) (26)
Serologic responses and systemic reactions in adults after vaccination with bivalent A/Victoria/75-A/New Jersey/76 and monovalent B/Hong Kong/72 influenza vaccines. (1977) (26)
Acute diarrheal infections in infants I. Bacterial and viral causes. (1980) (26)
Defective local leukocyte mobilization in children with kwashiorkor. (1977) (26)
Dengue virus infection. (2003) (25)
Experimental transmission of Japanese encephalitis virus by Culex fuscocephala. (1972) (24)
Atypical antibody responses in dengue vaccine recipients. (2003) (24)
Specific Role of Each Human Leukocyte Type in Viral Infections (1968) (24)
Does antigenic overload exist? The role of multiple immunizations in infants. (2003) (23)
Perspective on the development of vaccines against Lyme disease. (1991) (23)
Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults. (1996) (23)
Prevention and treatment of infectious diarrhea. Speculations on the next 10 years. (1985) (22)
Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. (1973) (22)
Ethical issues involving volunteers in AIDS vaccine trials. (1990) (21)
From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research. (2007) (20)
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae. (1993) (20)
Development of standard clinical endpoints for use in dengue interventional trials (2018) (20)
Clinical evaluation of adjuvants (2006) (19)
Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites. (2002) (19)
T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. (1992) (18)
From the National Institute of Allergy and Infectious Diseases. Summary of an International Symposium on potentiation of the immune response to vaccines. (1980) (18)
Phase II safety and immunogenicity study of type F botulinum toxoid in adult volunteers. (2003) (18)
Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis. (1979) (17)
The Oxford Handbook of Sports History (2017) (16)
Unique challenges faced by the clinical evaluation of dengue vaccines (2011) (15)
Vaccine adjuvants. (1980) (15)
Summary of a workshop on maternal genitourinary infections and the outcome of pregnancy. (1983) (14)
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli. (1983) (13)
Dengue virus-specific, human CD4+ cytotoxic T lymphocytes generated in short-term culture. (1993) (13)
A simple, quantitative, reproducible avidin-biotin ELISA for the evaluation of group B streptococcus type-specific antibodies in humans. (1996) (13)
Obesity: does it modulate infectious disease and immunity? (1981) (13)
Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas (2010) (12)
Urinary neopterin in volunteers experimentally infected with Plasmodium falciparum. (1992) (11)
Chimeric Vaccines Against Japanese Encephalitis, Dengue, and West Nile (2004) (10)
Limited potential for transmission of live dengue virus vaccine candidates by Aedes aegypti and Aedes albopictus. (2000) (9)
Future vaccines against enteric pathogens. (1990) (9)
Ingwavuma virus in Thailand. Infection of domestic pigs. (1974) (8)
Ultra sonographic measurements of the normal liver and spleen among Egyptians 10-50 years old. (1997) (8)
The Controlled Human Malaria Infection Experience at the University of Maryland. (2019) (7)
The seventh international congress on Lyme Borreliosis: progress on the development of Lyme disease vaccines (1995) (7)
Plants as a Production and Delivery Vehicle for Orally Delivered Subunit Vaccines (2004) (7)
Classification of HTLV-III/LAV-related diseases [letter] (1985) (7)
Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines. (1994) (7)
Summary of the National Institutes of Health Research Workshop on the Epidemiology of the Acquired Immunodeficiency Syndrome (AIDS) (1984) (6)
Scientific Integrity: Text and Cases in Responsible Conduct of Research. (2006) (6)
A Promising, Single-Dose, Live Attenuated Tetravalent Dengue Vaccine Candidate. (2015) (6)
Hepatitis C virus (1995) (6)
Summary of the 22nd United States-Japan Joint Cholera Conference. (1984) (6)
The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route (2020) (6)
The impact of infections on medical care in the United States. Problems and priorities for future research. Proceedings of a symposium held at NIH Clinical Center, Bethesda, Maryland, U.S.A., 30-31 May 1978. (1978) (5)
Obesity, Type 2 Diabetes, and Cardiovascular Disease (2005) (5)
Female-to-male transmission of AIDS. (1985) (5)
Malnutrition and leprosy--an analytical review. (1979) (5)
Vaccines: new technologies and applications. 22-24 March 1993, the Madison Hotel, Washington, DC, USA. (1993) (5)
From the National Institute of Allergy and Infectious Diseases. Summary of the 19th United States-Japan Joint Cholera Conference. (1984) (4)
Treatment of gastrointestinal infections (1991) (4)
Erratum: Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system (Infection and Immunity 65:8 (3383)) (1997) (4)
Immunity to rotaviruses. (1989) (4)
From the National Institutes of Health. Summary of the International Symposium and Workshop on Infections due to Verocytotoxin (Shiga-like toxin)-producing Escherichia coli. (1988) (4)
The Suitability of HIV-Positive Individuals for Marriage and Pregnancy-Reply (1989) (4)
From The National Institutes of Health. Summary of the National Institutes of Health Research Workshop on the Epidemiology of the Acquired Immunodeficiency Syndrome (AIDS). (1984) (3)
Dengue illness index—A tool to characterize the subjective dengue illness experience (2018) (3)
The Sixth International Conference on Lyme Borreliosis: progress on the development of Lyme disease vaccines. 19-22 June 1994, Bologna, Italy. (1995) (3)
Infant Nutrition and Immunity (1990) (3)
Sequential immunization of laboratory personnel with influenza A/New Jersey/76 split- and whole-virus vaccines. (1977) (2)
Onset and Duration of Protective Immunity in Challenged Volunteers after Vaccination with Live Oral Cholera Vaccine CVD l03-HgR (2010) (2)
Cell-Mediated Immunity in Protein-Calorie Malnutrition (1975) (2)
Children and sport (1996) (2)
A new test of delayed hypersensitivity to measles virus in vitro (1971) (2)
Effects of ingested human anti-sporozoite sera on Plasmodium falciparum sporogony in Anopheles stephensi. (1993) (2)
Unusual persistence in healthy volunteers and ill patients of hyperimmune immunoglobulin directed against multiple Pseudomonas O-chain and Klebsiella serotypes after intravenous infusion. (2001) (2)
Controlled study of streptococcal endocarditis--a problem of feasibility. (1979) (2)
Vaccine Strategies to Prevent Dengue (2009) (1)
Clinical Research and the Law (2012) (1)
Oral immunization symposium. (1989) (1)
Explaining Cold War Sport (2019) (1)
Cutaneous hypersensitivity in protein-calorie malnutrition. (1973) (1)
Prospects for controlling dengue spread: vaccines and vector control (2014) (1)
The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route (2020) (0)
Epstein T Cell Immunity + Hepatic CD 8 Live Attenuated Malaria Vaccine Designed to Protect Through (2014) (0)
INTRODUCTION:: Explaining Cold War Sport (2019) (0)
54 ERYTHROCYTE METABOLISM IN ICTERIC TERM AND PREMATURE NEWBORN INFANTS (1979) (0)
5. The Golden Age of Soviet Soccer: Spartak in Eclipse, 1945–1948 (2017) (0)
Dengue and dengue vaccines [editorial] (2005) (0)
Defective monocyte/macrophage mobilization into the local inflammatory lesion in children with kwashiorkor. (2012) (0)
1. A Theoretical Debate, a Political Struggle (2017) (0)
Landes Highlights (2013) (0)
Erratum to “Immediate-type hypersensitivity and other clinical reactions in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum” [Vaccine 21 (2003) 269–280] (2003) (0)
2. Econorny and Society in the Southwest (2017) (0)
Vibrio cholerae . attenuated cholera vaccines and by El Tor and in diarrhea caused by selected new , live New evidence for an inflammatory component (1996) (0)
Vaccines for the future. (1983) (0)
LIMITED TRANSMISSION LIVE DENGUE VACCINE CANDIDATES BY AEDES AEGYPTI AND AEDES ALBOPICTUS (2001) (0)
Abdominal ultra sonographic findings detected in the course of a hepatitis survey in an Egyptian rural area. (1998) (0)
STIC j ) Efet / Single-Nutrient Effects oon Immunologic Functions 0 (0)
4. On Top and Bottom, 1937–1944 (2017) (0)
Immunologic and clinical evaluation of an inactivated venezuelan equine encephalomyelitis virus vaccine in man (1977) (0)
5. The Consequences of the Prussian Path (2017) (0)
3. The Battle Is Joined, 1936–1937 (2017) (0)
Cigarette smoking among vermonters with diabetes, 2000 to 2003 (2004) (0)
[Orientation of the young athlete]. (1994) (0)
4. A Peasant Movernent-Patterns and Participants (2017) (0)
Dr Edelman responds (1996) (0)
6. Spartak Resurgent, 1949–1952 (2017) (0)
9. Uncertainly Ever After, 1964–1991 (2017) (0)
1. Spartak’s Roots: Futbol in the ’Hood, 1900–1917 (2017) (0)
Persistence of Human Antibody to Venezuelan Equine Encephalomyelitis (VEE) Virus Subtypes after Immunization with Attenuated (TC-83) VEE Vaccine. (1976) (0)
Enteric vaccines. (1991) (0)
3. A Strike Movernent-Dernands and Tactics (2017) (0)
[Sports in children and adolescents]. (2002) (0)
The Vietnam War (2003) (0)
7. Thaw, Change, and Resurrection, 1953–1956 (2017) (0)
2. Before There Was Spartak, 1917–1935 (2017) (0)
8. Good-bye, Golden Age, 1957–1964 (2017) (0)
[Nurse's role in labor wards operating as intensive care units]. (1974) (0)
Some Words on Usage (2017) (0)
Results of a Phase I/II Randomized Immunotherapy Trial Testing Adoptive Transfer of Co-Stimulated Autologous T Cells and Pneumococcal Conjugate Vaccine (PCV) Immunization after Autotransplantation for Myeloma (MM). (2004) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert R. Edelman?

Robert R. Edelman is affiliated with the following schools:

University of Maryland, College Park

Robert R. Edelman's Academic­Influence.com Rankings

Robert R. Edelman's Degrees

Why Is Robert R. Edelman Influential?

Robert R. Edelman's Published Works

Published Works

What Schools Are Affiliated With Robert R. Edelman?

Robert R. Edelman's AcademicInfluence.com Rankings